Corebridge Financial, Inc. - 09 Sep 2024 Form 4 Insider Report for ClearBridge MLP & Midstream Fund Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Sep 2024, 16:05:37 UTC
Prior SEC filing
31 Jul 2024
Next SEC filing
24 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christine A. Nixon, Authorized Signatory of Corebridge Financial, Inc.

Key filing fact

Corebridge Financial, Inc. filed Form 4 for ClearBridge MLP & Midstream Fund Inc. on 11 Sep 2024.

Key facts

  • This page summarizes Corebridge Financial, Inc.'s Form 4 filing for ClearBridge MLP & Midstream Fund Inc..
  • 5 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Sep 2024, 16:05.

Change

  • Previous filing in this sequence was filed on 31 Jul 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CEM transaction

Series J Mandatory Redeemable Preferred Stock

Other

Transaction value
$0
Shares
-44
Change %
-100%
Price
$0.000000
Shares after
0
Date
09 Sep 2024
Ownership
Held through subsidiaries
Footnotes
F1, F2, F3
CEM transaction

Series K Mandatory Redeemable Preferred Stock

Other

Transaction value
$0
Shares
-82
Change %
-100%
Price
$0.000000
Shares after
0
Date
09 Sep 2024
Ownership
Held through subsidiaries
Footnotes
F1, F2, F4
CEM transaction

3.46% Senior Secured Notes Series I due June 11, 2025

Other

Transaction value
$0
Shares
-559,610
Change %
Price
$0.000000
Shares after
$0
Date
09 Sep 2024
Ownership
Held through subsidiaries
Footnotes
F1, F2, F5
CEM transaction

3.56% Senior Secured Notes Series J due June 11, 2027

Other

Transaction value
$0
Shares
-1,492,294
Change %
Price
$0.000000
Shares after
$0
Date
09 Sep 2024
Ownership
Held through subsidiaries
Footnotes
F1, F2, F6
CEM transaction

3.76% Senior Secured Notes Series K due June 11, 2030

Other

Transaction value
$0
Shares
-2,051,904
Change %
Price
$0.000000
Shares after
$0
Date
09 Sep 2024
Ownership
Held through subsidiaries
Footnotes
F1, F2, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Corebridge Financial, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 7 footnotes

Footnote F1

On September 9, 2024, pursuant to an Agreement and Plan of Merger, dated September 6, 2024, between ClearBridge Energy Midstream Opportunity Fund, Inc. ("EMO") and the Issuer, the Issuer merged with and into EMO (the "Merger").

Footnote F2

As a result of the Merger, among other things, (1) EMO issued and delivered to holders of the Issuer's Mandatory Redeemable Preferred Stock ("MRPS") newly issued shares of EMO's MRPS with the same aggregate liquidation preference and other terms as the CEM MRPS that were issued and outstanding immediately prior to the Merger (other than voting rights, which correspond to every $35 of liquidation preference in the case of the newly issued MRPS), and the Issuer's MRPS ceased to be outstanding and were automatically canceled and (2) EMO expressly assumed the obligations of the Issuer under, among other things, the Issuer's outstanding Senior Secured Notes (the "Notes") and, at the request of a holder of the Issuer's outstanding Notes, EMO issued replacement Notes with the same aggregate principal amount outstanding and terms as the Issuer's Notes. Any of the Issuer's Notes for which replacement Notes were issued ceased to be outstanding and were automatically canceled.

Footnote F3

Prior to the Merger, American General Life Insurance Company ("AGLIC") and The United States Life Insurance Company in the City of New York ("USL"), each an indirect wholly owned subsidiary of Corebridge Financial, Inc. ("CRBG"), directly held 1 share and 29 shares of the reported securities, respectively. Corebridge Institutional Investments, (U.S.), LLC ("CIIUS"), an indirect wholly owned subsidiary of CRBG, may have been deemed to have beneficial ownership of 14 shares of the reported securities held by a controlled subsidiary of American International Group, Inc. ("AIG"), pursuant to an investment management agreement. CRBG disclaims beneficial ownership of the securities held by the controlled subsidiary of AIG, and this report shall not be deemed an admission that CRBG was the beneficial owner of such securities, except to the extent of CRBG's pecuniary interest therein.

Footnote F4

Prior to the Merger, AGLIC directly held 56 shares of the reported securities. CIIUS may have been deemed to have beneficial ownership of 26 shares of the reported securities held by a controlled subsidiary of AIG, pursuant to an investment management agreement. CRBG disclaims beneficial ownership of the securities held by the controlled subsidiary of AIG, and this report shall not be deemed an admission that CRBG was the beneficial owner of such securities, except to the extent of CRBG's pecuniary interest therein.

Footnote F5

Prior to the Merger, AGLIC and The Variable Annuity Life Insurance Company, an indirect wholly owned subsidiary of CRBG, directly held $373,073.46 principal amount and $186,536.74 principal amount of the reported securities, respectively.

Footnote F6

Prior to the Merger, AGLIC directly held $1,492,293.86 principal amount of the reported securities.

Footnote F7

Prior to the Merger, AGLIC and USL directly held $1,380,371.82 principal amount and $671,532.25 principal amount of the reported securities, respectively.

SEC remarks

Filed pursuant to Section 30(h) of the Investment Company Act of 1940.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .